Patent classifications
C07C43/10
METHODS OF ETHERIFICATION
Embodiments of the present disclosure are directed towards methods of etherification including modifying a zeolite catalyst with silica to provide a silica modified zeolite catalyst; and contacting the silica modified zeolite catalyst with an olefin and an alcohol to produce a monoalkyl ether.
METHODS OF ETHERIFICATION
Embodiments of the present disclosure are directed towards methods of etherification including modifying a zeolite catalyst with silica to provide a silica modified zeolite catalyst; and contacting the silica modified zeolite catalyst with an olefin and an alcohol to produce a monoalkyl ether.
METHODS OF ETHERIFICATION
Embodiments of the present disclosure are directed towards methods of etherification including reducing templates of a zeolite catalyst to provide a reduced template zeolite catalyst having from 3 to 15 weight percent weight percent of templates maintained following calcination of zeolite catalyst; and contacting the reduced template zeolite catalyst with an olefin and an alcohol to produce a monoalkyl ether.
METHODS OF ETHERIFICATION
Embodiments of the present disclosure are directed towards methods of etherification including reducing templates of a zeolite catalyst to provide a reduced template zeolite catalyst having from 3 to 15 weight percent weight percent of templates maintained following calcination of zeolite catalyst; and contacting the reduced template zeolite catalyst with an olefin and an alcohol to produce a monoalkyl ether.
Wax Ethers and Related Methods
Implementations of a method of forming a wax ether composition may include: providing a batch of lipids, drying the batch of lipids, and cooling the batch of lipids. The method may also include dosing, with a catalyst, the batch of lipids at 0.1% to 0.3% by weight of the batch of lipids and dissolving the catalyst in the batch of lipids to form a homogenous solution. The method may include adding at least a molar equivalent of a hydrogen donor to the homogenous solution. The method may include sealing and maintaining the homogenous solution and hydrogen donor under atmospheric pressure under reflux until a chemical reaction between the homogenous solution and the hydrogen donor forms a product comprising an ether.
Wax Ethers and Related Methods
Implementations of a method of forming a wax ether composition may include: providing a batch of lipids, drying the batch of lipids, and cooling the batch of lipids. The method may also include dosing, with a catalyst, the batch of lipids at 0.1% to 0.3% by weight of the batch of lipids and dissolving the catalyst in the batch of lipids to form a homogenous solution. The method may include adding at least a molar equivalent of a hydrogen donor to the homogenous solution. The method may include sealing and maintaining the homogenous solution and hydrogen donor under atmospheric pressure under reflux until a chemical reaction between the homogenous solution and the hydrogen donor forms a product comprising an ether.
1,3-PROPYLENE ETHER DERIVED COMPOUNDS FOR PERSONAL CARE
A compound has the structure of formula (1): X(OCH.sub.2CH.sub.2CH.sub.2).sub.nOR (1) in which n is an integer from 2 to 15, R is a C.sub.6 to C.sub.36 hydrocarbyl group, X is R or R.sub.1C(O) and R.sub.1 is a C.sub.2 to C.sub.36 hydrocarbyl group. A personal care product contains the compound of formula (1). A method of producing the compound and the use of the compound as a sensory agent and/or pigment wetting agent in a cosmetic or personal care product are also disclosed.
1,3-PROPYLENE ETHER DERIVED COMPOUNDS FOR PERSONAL CARE
A compound has the structure of formula (1): X(OCH.sub.2CH.sub.2CH.sub.2).sub.nOR (1) in which n is an integer from 2 to 15, R is a C.sub.6 to C.sub.36 hydrocarbyl group, X is R or R.sub.1C(O) and R.sub.1 is a C.sub.2 to C.sub.36 hydrocarbyl group. A personal care product contains the compound of formula (1). A method of producing the compound and the use of the compound as a sensory agent and/or pigment wetting agent in a cosmetic or personal care product are also disclosed.
Quantum dot composition including a ligand bonded to a surface of a quantum dot, light emitting element including an emission layer containing a quantum dot and ligand residues, and method for manufacturing the same
A quantum dot composition includes a quantum dot, and a ligand bonded to a surface of the quantum dot, wherein the ligand includes a head portion bonded to the surface of the quantum dot and containing a polar solvent dissociative functional group, and a tail portion connected to the head portion. A quantum dot composition according to an embodiment is used to form an emission layer of a light emitting element to enhance luminous efficiency of the light emitting element including an emission layer formed through the quantum dot composition.
Quantum dot composition including a ligand bonded to a surface of a quantum dot, light emitting element including an emission layer containing a quantum dot and ligand residues, and method for manufacturing the same
A quantum dot composition includes a quantum dot, and a ligand bonded to a surface of the quantum dot, wherein the ligand includes a head portion bonded to the surface of the quantum dot and containing a polar solvent dissociative functional group, and a tail portion connected to the head portion. A quantum dot composition according to an embodiment is used to form an emission layer of a light emitting element to enhance luminous efficiency of the light emitting element including an emission layer formed through the quantum dot composition.